Related references
Note: Only part of the references are listed.Advances in IKBKE as a potential target for cancer therapy
Min Yin et al.
CANCER MEDICINE (2020)
Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
Julien Lefranc et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice
Valeria Gerbino et al.
NEURON (2020)
Small Molecule NF-κB Pathway Inhibitors in Clinic
Venkataramanan Ramadass et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor
Douglas W. Thomson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
TANK-binding kinase 1 as a novel therapeutic target for viral diseases
Chunyuan Zhao et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1
Andrew P. Crew et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Assessment of TANK-binding kinase 1 as a therapeutic target in cancer
Victoria H. Cruz et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue
Peng Zhao et al.
CELL (2018)
Type I interferon in rheumatic diseases
Theresa L. Wampler Muskardin et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity
Cynthia Louis et al.
FRONTIERS IN IMMUNOLOGY (2018)
Design of amidobenzimidazole STING receptor agonists with systemic activity
Joshi M. Ramanjulu et al.
NATURE (2018)
TBK1: a new player in ALS linking autophagy and neuroinflammation
James A. Oakes et al.
MOLECULAR BRAIN (2017)
Emergence of TNIK inhibitors in cancer therapeutics
Tesshi Yamada et al.
CANCER SCIENCE (2017)
Small-Molecule PROTACS: New Approaches to Protein Degradation
Momar Toure et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target
M. Obayed Ullah et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies
Maroof Hasan et al.
PHARMACOLOGICAL RESEARCH (2016)
TBK1 inhibitors: a review of patent literature (2011-2014)
Tao Yu et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
The concanavalin A model of acute hepatitis in mice
F. Heymann et al.
LABORATORY ANIMALS (2015)
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Axel Freischmidt et al.
NATURE NEUROSCIENCE (2015)
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Elizabeth T. Cirulli et al.
SCIENCE (2015)
IκB kinase ε (IKKε): A therapeutic target in inflammation and cancer
Kelly Verhelst et al.
BIOCHEMICAL PHARMACOLOGY (2013)
An inhibitor of the protein kinases TBK1 and IKK-ε improves obesity-related metabolic dysfunctions in mice
Shannon M. Reilly et al.
NATURE MEDICINE (2013)
TBK-1 Promotes Autophagy-Mediated Antimicrobial Defense by Controlling Autophagosome Maturation
Manohar Pilli et al.
IMMUNITY (2012)
The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling
Jin Jin et al.
NATURE IMMUNOLOGY (2012)
Novel cross-talk within the IKK family controls innate immunity
Kristopher Clark et al.
BIOCHEMICAL JOURNAL (2011)
The TRAF-associated protein TANK facilitates cross-talk within the IκB kinase family during Toll-like receptor signaling
Kristopher Clark et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality
Erica Marchlik et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The Protein Kinase IKKε Regulates Energy Balance in Obese Mice
Shian-Huey Chiang et al.
CELL (2009)
Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and IκB Kinase ε A DISTINCT UPSTREAM KINASE MEDIATES SER-172 PHOSPHORYLATION AND ACTIVATION
Kristopher Clark et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
M. Paula Longhi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Amlexanox for the treatment of recurrent aphthous ulcers
J Bell
CLINICAL DRUG INVESTIGATION (2005)
Share Paper
